Vallon Pharmaceuticals Reports Fiscal Year 2021 Financial Results and Provides Business Update
-Topline dataforpivotalabusestudy oftheCompany’s leadinvestigationalprogram ADAIRexpected this quarter
Source: kulr8.com
Page 2 - Abuse Liability News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Abuse Liability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Abuse Liability Today - Breaking & Trending Today
Vallon Pharmaceuticals Announces Achievement of Last
- Topline results from pivotal SEAL study expected in Q1 2022 - If approved, ADAIR will target the growing Adderall® segment of the ~$9 billion U.S....
Source: globenewswire.com
FinancialNewsMedia.com: Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics
PALM BEACH, Fla., Dec. 15, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs)
Source: finanznachrichten.de
Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs),...
Source: prnewswire.com
Relmada Therapeutics to Present Data at the 60th Annual Meeting of the American College of Neuropsychopharmacology
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),...
Source: prnewswire.com